Home » Topics » BioWorld Science

BioWorld Science
RSS

Circulating galectin-1 as a predictive biomarker of CAD and MACE in patients with stable angina

Sep. 6, 2019

CAD-1883 demonstrates promising safety in phase I study

Sep. 6, 2019

Potent AXL kinase inhibitor with promising in vitro and in vivo biological activity

Sep. 6, 2019

An organoid model for prenatal brain development

Sep. 6, 2019

Dystrophy mutation protects cells from HIV infection

Sep. 6, 2019

ADC traffic rules revealed

Sep. 6, 2019

New trials evaluate IPI-549 in combination therapies for solid tumors

Sep. 5, 2019

Gilead Sciences initiates phase Ib/II study of GS-4224 in advanced solid tumors

Sep. 5, 2019

CellCentric initiates phase I/IIa study of CCS-1477 in hematological malignancies

Sep. 5, 2019

Applied Therapeutics begins phase III study of AT-1001 for diabetic cardiomyopathy

Sep. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...